1. Home
  2. Stock quotes
  3. Pieris Pharmaceuticals
  4. Financial Statements
  5. Balance Sheet
Pieris Pharmaceuticals logo
Pieris Pharmaceuticals PIRS
$ 13.6 -15.58%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Pieris Pharmaceuticals Balance Sheet 2011-2024 | PIRS

Annual Balance Sheet Pieris Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

 -26.4 M -104 M -70.4 M -46 M -74.9 M -37.9 M -29.4 M -29.3 M -10.7 K -4.73 K - -

Long Term Debt

 - 12.2 M 13.8 M - - - - - - - - - -

Long Term Debt Current

 - 859 K - 1.03 M 733 K - - - - - - - -

Total Non Current Liabilities

 - - - 6 K 62.7 M 53.3 M 46.6 M 1.46 M 23.9 K - - - -

Total Current Liabilities

 11.9 M 36.6 M 50.6 M 22.1 M 27 M 48.1 M 45.8 M 8.38 M 2.8 M 3.54 M - - -

Total Liabilities

 11.9 M 67.6 M 103 M 74 M 89.7 M 101 M 92.4 M 9.84 M 2.82 M 1.12 K 474 - -

Deferred Revenue

 - 20.8 M 25.1 M 12.6 M 11.3 M 35.6 M 37.2 M 2.27 M - - - - -

Retained Earnings

 -315 M -290 M -257 M - -174 M -147 M -120 M -103 M -79.9 M -16 K -274 - -

Total Assets

 38.7 M 95.5 M 154 M 105 M 141 M 141 M 104 M 35.1 M 34 M 11.1 K 5.2 K - -

Cash and Cash Equivalents

 17.4 M 38.6 M 118 M 70.4 M 62.3 M 74.9 M 37.9 M 29.4 M 29.3 M 18.5 M 3.69 M - -

Book Value

 26.8 M 27.9 M 50.8 M 31 M 51.4 M 39.9 M 11.5 M 25.2 M 31.1 M 10 K 4.73 K - -

Total Shareholders Equity

 26.8 M 27.9 M 50.8 M 31 M 51.4 M 39.9 M 11.5 M 25.2 M 31.1 M 18 M 585 K - -

All numbers in USD currency

Quarterly Balance Sheet Pieris Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

 - - - - - 11.9 M - 12.2 M 11.4 M - 13.4 M 13.8 M 14.4 M 15 M 15 M 15.9 M 15.9 M 15.9 M 15.9 M 15.5 M 15.5 M 15.5 M 15.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

 - - - - 28.9 M 47 M - 67.6 M 63.4 M - 83.7 M 103 M 110 M 108 M 77.6 M 74 M 74 M 74 M 74 M 89.7 M 89.7 M 89.7 M 89.7 M 101 M 101 M 101 M 101 M 92.4 M 92.4 M 92.4 M 92.4 M 9.84 M 9.84 M 9.84 M 9.84 M 2.82 M 2.82 M 2.82 M 2.82 M 3.85 M 3.88 M 3.88 M 3.88 M 6.69 M 474 3.32 K - - - - - - - - -

Deferred Revenue

 - - - - 994 K 17.7 M - 20.8 M 18.5 M - 20.9 M 25.1 M 26.4 M 25.5 M 17.2 M 12.6 M 12.6 M 12.6 M 12.6 M 11.3 M 11.3 M 11.3 M 11.3 M 35.6 M 31.9 M 44.6 M 46.3 M 37.2 M 37.2 M 37.2 M 37.2 M 2.28 M 2.27 M 2.27 M 2.27 M - - - - - - - - 545 K - - - - - - - - - - -

Retained Earnings

 -326 M -323 M -320 M -315 M -310 M -300 M - -290 M -282 M - -262 M -257 M -248 M -231 M -216 M -211 M -211 M -211 M -211 M -174 M -174 M -174 M -174 M -147 M -147 M -147 M -147 M -120 M -120 M -120 M -120 M -103 M -103 M -103 M -103 M -79.9 M -79.9 M -79.9 M -79.9 M -65.8 M -65.8 M -65.8 M -65.8 M -56 M -274 -8.23 K - - - - - - - - -

Total Assets

 20.5 M 25.1 M 29.5 M 38.7 M 59.4 M 87.5 M - 95.5 M 99.2 M - 137 M 154 M 164 M 155 M 116 M 105 M 105 M 105 M 105 M 141 M 141 M 141 M 141 M 141 M 141 M 141 M 141 M 104 M 104 M 104 M 104 M 35.1 M 35.1 M 35.1 M 35.1 M 34 M 34 M 34 M 34 M 21.9 M 21.9 M 21.9 M 21.9 M 7.28 M 5.2 K 90 - - - - - - - - -

Cash and Cash Equivalents

 19.4 M 19.7 M 19.1 M 17.4 M 32.9 M 44.9 M - 38.6 M 48.4 M - 83.7 M 118 M 125 M 119 M 66.8 M 70.4 M 70.4 M 70.4 M 70.4 M 62.3 M 62.3 M 62.3 M 62.3 M 74.9 M 74.9 M 74.9 M 74.9 M 37.9 M 37.9 M 37.9 M 37.9 M 29.4 M 29.4 M 29.4 M 29.4 M 29.4 M 29.3 M 29.3 M 29.3 M 18.5 M 18.5 M 18.5 M 18.5 M 3.69 M 90 90 - 6.33 M - - - - - - -

Book Value

 - - - - 30.5 M 40.5 M - 27.9 M 35.8 M - 53.4 M 50.8 M 53.9 M 46.7 M 38.2 M 31 M 31 M 31 M 31 M 51.4 M 51.4 M 51.4 M 51.4 M 39.9 M 39.9 M 39.9 M 39.9 M 11.5 M 11.5 M 11.5 M 11.5 M 25.2 M 25.2 M 25.2 M 25.2 M 31.1 M 31.1 M 31.1 M 31.1 M 18 M 18 M 18 M 18 M 585 K 4.73 K -3.23 K - - - - - - - - -

Total Shareholders Equity

 16.3 M 18.7 M 22 M 26.8 M 30.5 M 40.5 M 15.5 M 27.9 M 35.8 M - 53.4 M 50.8 M 53.9 M 46.7 M 38.2 M 31 M 31 M 31 M 31 M 51.4 M 51.4 M 51.4 M 51.4 M 39.9 M 39.9 M 39.9 M 39.9 M 11.5 M 11.5 M 11.5 M 11.5 M 25.2 M 25.2 M 25.2 M 25.2 M 31.1 M 31.1 M 31.1 M 31.1 M 18 M 18 M 18 M 18 M 585 K 4.73 K 4.73 K - 496 K - - - - - - -

All numbers in USD currency